If considering a dose reduction for maintenance: Wait until weight has stabilized for at least 4 weeks at your current dose Reduce by one dose step (e.g., 12mg to 8mg), do not jump multiple steps Monitor weight closely for 8 weeks after the reduction If weight begins to increase, return to the previous maintenance dose The phase 3 trials specifically tested 4mg as a maintenance dose, suggesting Lilly sees viability in lower maintenance doses What happens if you stop Weight regain after discontinuing GLP-1 agonists is well documented with semaglutide and tirzepatide
Daily versus weekly formulation timing The timing calculus changes completely for daily GLP-1 formulations like liraglutide
GLP-1 medications are a class of drugs that mimic the action of the GLP-1 hormone, which is naturally produced in the body
The initial data is a powerful indicator of what's possible, but the next wave of discovery will come from independent labs like yours
Your provider should handle this, but follow up proactively
Regulatory agencies like the FDA require strong safety databases for drugs that will be prescribed to millions of people, and a trial of this size provides the statistical power needed to detect both efficacy signals and uncommon adverse events
